81 FR 71504 - World Trade Center Health Program Scientific/Technical Advisory Committee (WTCHP STAC or Advisory Committee), National Institute for Occupational Safety and Health (NIOSH)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 81, Issue 200 (October 17, 2016)

[Federal Register Volume 81, Number 200 (Monday, October 17, 2016)]
[Notices]
[Pages 71504-71505]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-25039]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Docket Number CDC-2016-0093; NIOSH 248-F]


World Trade Center Health Program Scientific/Technical Advisory 
Committee (WTCHP STAC or Advisory Committee), National Institute for 
Occupational Safety and Health (NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
committee:
    Time and Date: 9:00 a.m.-5:00 p.m., November 3, 2016 (All times are 
Eastern Daylight Time).
    Place: Jacob J. Javits Federal Building, 26 Federal Plaza, New 
York, New York 10278. This meeting is also available by telephone and 
Web conference. Audio will be available by telephone only; visuals will 
be available by Web conference. The USA toll-free, dial-in number is 1-
888-810-4931, and when prompted enter passcode--8328289. To view the 
web conference, enter the following web address in your web browser: 
https://odniosh.adobeconnect.com/wtchpstac/.
    Public Comment Time and Date: 10:45 a.m.-11:15 a.m. (Eastern 
Daylight Time), November 3, 2016.
    Please note that the public comment period ends at the time 
indicated above or following the last call for comments, whichever is 
earlier. Members of the public who want to comment must sign up by 
providing their name by mail, email, or telephone, at the addresses 
provided below by October 31, 2016. Each commenter will be provided up 
to five minutes for comment. A limited number of time slots are 
available and will be assigned on a first come--first served basis. 
Written comments will also be accepted from those unable to attend the 
public session.
    Status: Open to the public, limited only by the number of telephone 
lines. The conference line will accommodate up to 50 callers. The room 
will accommodate approximately 100 persons.
    Background: The Advisory Committee was established by Title I of 
the James Zadroga 9/11 Health and Compensation Act of 2010, Public Law 
111-347 (January 2, 2011), amended by Public Law 114-113 (Dec. 18, 
2015), adding Title XXXIII to the Public Health Service Act (codified 
at 42 U.S.C. 300mm to 300mm-61).
    Purpose: The purpose of the Advisory Committee is to review 
scientific and medical evidence and to make recommendations to the 
World Trade Center (WTC) Program Administrator regarding additional WTC 
Health Program eligibility criteria, potential additions to the list of 
covered WTC-related health conditions, and research regarding certain 
health conditions related to the September 11, 2001 terrorist attacks.
    Title XXXIII of the PHS Act established the WTC Health Program 
within the Department of Health and Human Services (HHS). The WTC 
Health Program provides medical monitoring and treatment benefits to 
eligible firefighters and related personnel, law enforcement officers, 
and rescue, recovery, and cleanup workers who responded to the 
September 11, 2001, terrorist attacks in New York City, at the 
Pentagon, and in Shanksville, Pennsylvania (responders), and to 
eligible persons who were present in the dust or dust cloud on 
September 11, 2001 or who worked, resided, or attended school, 
childcare, or adult daycare in the New York City disaster area 
(survivors). Certain specific activities of the WTC Program 
Administrator are reserved to the Secretary, HHS, to delegate at her 
discretion; other WTC Program Administrator duties not explicitly 
reserved to the Secretary, HHS, are assigned to the Director, NIOSH. 
The administration of the Advisory Committee is left to the Director of 
NIOSH in his role as WTC Program Administrator. CDC and NIOSH provide 
funding, staffing, and administrative support services for the Advisory 
Committee. The charter was reissued on May 12, 2015, and will expire on 
May 12, 2017.
    Matters for Discussion: The Advisory Committee will address the new 
responsibilities required under the reauthorization of the WTC Health 
Program in the PHS Act. Specifically, the enhanced role of the STAC to: 
(1) Make recommendations regarding the identification of individuals to 
conduct independent peer reviews of the evidence that would be the 
basis for issuing final rules to add a health condition to the List of 
WTC-Related Health Conditions; and (2) review and evaluate the policies 
and procedures in effect within the WTC Health Program that are used to 
determine whether sufficient evidence is available to support adding a 
non-cancer condition or type of cancer to the List of WTC-Related 
Health Conditions.
    The two policies can be found at: http://www.cdc.gov/wtc/policies.html.
    The agenda will include workgroup presentations on independent peer 
review and the policies and procedures the WTC Health Program uses to 
add health conditions to the list of covered conditions.
    The agenda is subject to change as priorities dictate.
    To view the notice, visit http://www.regulations.gov and enter CDC-
2016-0093 in the search field and click ``Search.''
    Public Comment Sign-up and Submissions to the Docket: To sign up to 
provide public comments or to submit comments to the docket, send 
information to the NIOSH Docket Office by one of the following means:
    Mail: NIOSH Docket Office, Robert A. Taft Laboratories, MS C-34, 
1090 Tusculum Avenue, Cincinnati, Ohio 45226.
    Email: ni[email protected].
    Telephone: (513) 533-8611.
    In the event an individual cannot attend, written comments may be 
submitted. The comments should be limited to two pages and submitted 
through http://www.regulations.gov by October 31, 2016. Efforts will be 
made to provide the two-page written comments received by the deadline 
above to the committee members before the meeting. Comments in excess 
of two pages will be made publicly available at http://www.regulations.gov.
    Policy on Redaction of Committee Meeting Transcripts (Public 
Comment): Transcripts will be prepared and posted to http://www.regulations.gov within 60 days after the meeting. If a person 
making a comment gives his or her name, no attempt will be made to 
redact that name. NIOSH will take reasonable steps to ensure that 
individuals making public comments are aware of the fact that their 
comments (including their name, if provided) will appear in a 
transcript of the meeting posted on a public Web site. Such reasonable 
steps include a statement read at the start of the meeting stating that 
transcripts will be posted and names of speakers will not be redacted. 
If individuals in making a statement reveal personal information (e.g., 
medical information) about themselves, that information will not 
usually be redacted. The CDC Freedom of Information Act coordinator 
will, however, review such revelations

[[Page 71505]]

in accordance with the Freedom of Information Act and, if deemed 
appropriate, will redact such information. Disclosures of information 
concerning third party medical information will be redacted.
    Contact person for more information: Paul J. Middendorf, Ph.D., 
Designated Federal Officer, NIOSH, CDC, 2400 Century Parkway NE., Mail 
Stop E-20, Atlanta, Georgia 30345, telephone 1 (888) 982-4748; email: 
[email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention, and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2016-25039 Filed 10-14-16; 8:45 am]
 BILLING CODE 4163-18-P